ATE408827T1 - Quantifizierung von stressbelastung - Google Patents
Quantifizierung von stressbelastungInfo
- Publication number
- ATE408827T1 ATE408827T1 AT03810513T AT03810513T ATE408827T1 AT E408827 T1 ATE408827 T1 AT E408827T1 AT 03810513 T AT03810513 T AT 03810513T AT 03810513 T AT03810513 T AT 03810513T AT E408827 T1 ATE408827 T1 AT E408827T1
- Authority
- AT
- Austria
- Prior art keywords
- stress
- neutrophils
- quantification
- psychological
- methodology
- Prior art date
Links
- 238000011002 quantification Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 210000000440 neutrophil Anatomy 0.000 abstract 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 230000010485 coping Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Ecology (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0225885.3A GB0225885D0 (en) | 2002-11-06 | 2002-11-06 | Quantifying exposure to stress |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE408827T1 true ATE408827T1 (de) | 2008-10-15 |
Family
ID=9947318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03810513T ATE408827T1 (de) | 2002-11-06 | 2003-11-05 | Quantifizierung von stressbelastung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7838262B2 (de) |
| EP (1) | EP1558929B1 (de) |
| JP (1) | JP4571864B2 (de) |
| AT (1) | ATE408827T1 (de) |
| AU (1) | AU2003276448A1 (de) |
| DE (1) | DE60323661D1 (de) |
| DK (1) | DK1558929T3 (de) |
| ES (1) | ES2312854T3 (de) |
| GB (1) | GB0225885D0 (de) |
| WO (1) | WO2004042395A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201616640D0 (en) * | 2016-09-30 | 2016-11-16 | Sarphie David And Mian Rubina | Monitoring cancer recurrence and progression |
| EP4614145A3 (de) * | 2019-06-27 | 2025-12-17 | Binary LLC | Chemilumineszenztest auf oxidasebasis von phagozytischen leukozyten in vollblut und körperflüssigkeiten für poc-testtestpunkt-f-messung |
| WO2022136850A1 (en) | 2020-12-22 | 2022-06-30 | Seroxo Limited | Method for diagnosing and monitoring sepsis |
| GB2619197B (en) | 2021-02-02 | 2025-12-17 | Seroxo Ltd | Monitoring COVID-19 progression and treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5401640A (en) * | 1992-03-30 | 1995-03-28 | Trustees Of Dartmouth College | Method for enhancing detection of superoxide anion |
| US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| EP1262167A1 (de) * | 2001-06-01 | 2002-12-04 | Cognis France S.A. | Kosmetische Zubereitungen enthaltend ein Extrakt von keimenden Pflanzen |
| BE1014949A3 (fr) * | 2001-08-14 | 2004-07-06 | Probiox | Procede de detection de stress oxydant et trousse pour sa mise en oeuvre. |
| KR20070007837A (ko) * | 2004-03-23 | 2007-01-16 | 라이프라인 뉴트러세티컬스 코포레이션 | 포유류에서 염증과 산화적 스트레스 완화를 위한 조성물 및방법 |
-
2002
- 2002-11-06 GB GBGB0225885.3A patent/GB0225885D0/en not_active Ceased
-
2003
- 2003-11-05 JP JP2004549334A patent/JP4571864B2/ja not_active Expired - Lifetime
- 2003-11-05 DK DK03810513T patent/DK1558929T3/da active
- 2003-11-05 ES ES03810513T patent/ES2312854T3/es not_active Expired - Lifetime
- 2003-11-05 AU AU2003276448A patent/AU2003276448A1/en not_active Abandoned
- 2003-11-05 US US10/533,935 patent/US7838262B2/en not_active Expired - Lifetime
- 2003-11-05 EP EP03810513A patent/EP1558929B1/de not_active Expired - Lifetime
- 2003-11-05 AT AT03810513T patent/ATE408827T1/de active
- 2003-11-05 WO PCT/GB2003/004749 patent/WO2004042395A1/en not_active Ceased
- 2003-11-05 DE DE60323661T patent/DE60323661D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004042395A1 (en) | 2004-05-21 |
| ES2312854T3 (es) | 2009-03-01 |
| EP1558929B1 (de) | 2008-09-17 |
| JP2006505263A (ja) | 2006-02-16 |
| EP1558929A1 (de) | 2005-08-03 |
| AU2003276448A1 (en) | 2004-06-07 |
| DE60323661D1 (de) | 2008-10-30 |
| US7838262B2 (en) | 2010-11-23 |
| DK1558929T3 (da) | 2009-01-26 |
| US20060014235A1 (en) | 2006-01-19 |
| JP4571864B2 (ja) | 2010-10-27 |
| GB0225885D0 (en) | 2002-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60228557D1 (de) | Candida-nachweis | |
| DE60314500D1 (de) | Diaminopyrimidine und deren verwendung als angiogenesehemmer | |
| EP1677097A4 (de) | Verfahren und system zur bestimmung der konzentration eines fluoreszenzpigments | |
| FI20041323A0 (fi) | Analysoija, järjestelmä ja menetelmä toivotun käyttäjäjoukon määrittämiseksi | |
| FI20011877L (fi) | Menetelmä ja bioanturi analyysiä varten | |
| WO2005047860A3 (en) | Antibodies to alpha-synuclein | |
| WO2003066876A3 (en) | An apparatus and methods for using biological material to discriminate an agent | |
| EP1557653A4 (de) | Pedalkraftsensor und pedalkraft-erfassunfgsvorrichtung mittels diesem sensor | |
| WO2004055519A3 (en) | Specific markers for pancreatic cancer | |
| WO2004081521A3 (en) | Methods for direct detection of individual methotrexate metabolites | |
| ATE378404T1 (de) | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon | |
| MXPA05006382A (es) | Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal. | |
| FI20030547A0 (fi) | Menetelmä ja järjestelmä sydänanalyysiä varten | |
| EP1643894A4 (de) | Verfahren, kits und antikörper zum nachweis von parathyroid | |
| NO20031465L (no) | System og måling av forskyvning, samt fremgangsmåte | |
| WO2005034737A3 (en) | Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases | |
| DE60323661D1 (de) | Quantifizierung von stressbelastung | |
| WO2004113574A3 (en) | Methods for disease screening | |
| TW200508936A (en) | The establishment of proteome structure profile databases and their uses | |
| WO2005011612A3 (en) | Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism | |
| DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
| WO2007060647A3 (en) | A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels | |
| DE112006001250A5 (de) | Messgerät, Messverfahren, Messleitung und Elektrode | |
| DK1257830T3 (da) | Assay til måling af holo-transcobalamin og folat | |
| FR2852096B1 (fr) | Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1558929 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |